Simultaneous quantification of nirmatrelvir and ritonavir by LC-MS/MS in patients treated for COVID-19
Jens Martens‐Lobenhoffer, Corinna R. Böger, Jan T. Kielstein, Stefanie M. Bode‐Böger
Topics & Concepts
RitonavirChemistryChromatographyCoronavirus disease 2019 (COVID-19)AnalyteTherapeutic drug monitoringSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Liquid chromatography–mass spectrometryPharmacologyDrugMass spectrometryViral loadVirusVirologyMedicineInternal medicineAntiretroviral therapyDiseaseInfectious disease (medical specialty)Antibiotics Pharmacokinetics and EfficacySARS-CoV-2 detection and testingPesticide Residue Analysis and Safety